Company Overview

Development Stage

About the Company

Quintara Biosciences于2005年在美国加州成立,是一家专注于生命科学技术的生物科技公司。

US总部位于波士顿,在休斯顿、旧金山等多地设有分支机构。同时,中国区总部位于江苏南京(南京昆佰泰生物技术有限公司,Quinbio),中国区布局涵盖销售、基因合成及测序业务。

公司拥有四大核心技术平台(DNA读取、DNA合成、DNA制备、DNA表达),涵盖测序、基因合成、质粒制备等前沿领域,依托NGS、Nanopore测序等尖端技术,助力学术研究与药物研发提速。

我们以质量、速度和价值为核心,重视人才成长,诚邀优秀学子加入,共筑生命科学创新未来。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Recruitment Overview / Current Status (14 open positions)

Manage
Note: How fast is hiring at 南京昆佰泰生物技术有限公司 growing? 2026: 27 openings, 2025: 37 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
+100%
Growth Rate
2026 vs 2025
Master's Hiring by Year: 2026 — 3 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 南京昆佰泰生物技术有限公司 growing? Master's recruitment over the years: 2026: 6 openings, 2025: 3 openings.

— What Are the Salaries Like? (33 records)

Manage
salary range: 2K - 50K, 39.4% of roles pay ¥8-15K
Note: salary statistics are based on 33 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 南京昆佰泰生物技术有限公司?39.4% of positions earn 8-15K, Undergraduate salary: ¥。生物/制药/化工/环保类 average salary ¥12.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 南京昆佰泰生物技术有限公司? We provide: 实习生,实验员,ma,sa,会计,技术支持,销售,bi,cs,ie,产品经理,人事,全栈工程师,生物技术,行政,it工程师,供应链,化学,市场,抗体发现. Click to view detailed salary analysis by job.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 生物/制药/化工/环保类
    27.3% of total 27.3%
  • 在校学生类
    21.2% of total 21.2%
  • 计算机/网络/技术类
    21.2% of total 21.2%
  • 质量管理类
    18.2% of total 18.2%

Education

  • 本科
    54.5% of total 54.5%
  • 大专
    21.2% of total 21.2%
  • 硕士
    18.2% of total 18.2%
  • 博士
    3% of total 3%

Experience

  • 不限
    57.6% of total 57.6%
  • 1-3年
    24.2% of total 24.2%
  • 3-5年
    18.2% of total 18.2%
View Detailed Analysis

What does 南京昆佰泰生物技术有限公司 require? Who is 南京昆佰泰生物技术有限公司 hiring? recruitment: 生物/制药/化工/环保类占比最多占27.3%,其次是在校学生类占21.2%. What education can get in at ? 本科占比最多占54.5%,其次是大专占21.2%. High education required at ? 硕士占18.2%,博士占3%. Work experience required at ? 不限占比最多占57.6%,其次是1-3年占24.2%. Where are the job locations at ? 南京占比最多占87.9%,其次是上海占3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 500万(美元)
Legal Representative: 杜晓波
Date Established:
Credit Code: 91320191MADTX1BD6U
Registered Address: 南京江北新区研创园华创路73号A座1401室

Partners & Suppliers

委托药明康德进行化合物合成及分析测试服务 Source
供应商 CRO/CMO
与中国药科大学签署产学研合作协议,共同开发药物中间体 Source
供应商 高校/研究院合作
与南京大学生命科学学院共建联合实验室,开展生物技术研发合作 Source
供应商 高校/研究院合作

People who follow this company also follow

Competitors (Similar Companies)

生物科技/生物工程 医药 基因合成 生物医药
“基因组研究和基因技术应用”
基因检测 分子生物学 医学检验所 临床诊断
“为全球市场提供医疗器械产品”
临床试验 精准医疗 探头 医疗科技
食品 饮料 生产 非酒精饮料
医药 生命科学 多肽合成 抗体
医疗器械 诊断试剂 POCT 快速诊断试剂
“ADAS driving assistance solution supplier”
伴随诊断 生物基材料 基因工程 生物制品
制药/药业 医药 生物制品 生物制药
“Focused on developing high-throughput sequencing experimental technolo”
生物科技/生物工程 分子生物学试剂 核酸纯化 核苷酸
智能制造/生产/加工 先进制造 协作机器人 穿刺机器人
科研服务 分子遗传 医学检验所 第三方医学检验

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates